REGULATORY

REGULATORY

The Regulatory Workgroup engages with stakeholders to discuss the appropriate regulatory framework for advanced diagnostic tests... Read More »
REIMBURSEMENT

REIMBURSEMENT

The Reimbursement Workgroup is playing a lead role in crafting the future of coding, coverage, and payment for ADLTs... Read More »
INTELLECTUAL PROPERTY

INTELLECTUAL PROPERTY

The Intellectual Property Workgroup is deeply committed to advocacy for protection of intellectual property rights for innovators... Read More »

Advanced Diagnostics Are Key to the Future of Quality, Affordable Healthcare

The Coalition for 21st Century Medicine represents some of the world’s most innovative diagnostic technology companies, clinical laboratories, researchers, physicians, venture capitalists, and patient advocacy groups – all linked by a common mission to develop and make available state-of-the-art diagnostics that improve patient health.

Latest Press Release

Coalition for 21st Century Medicine Supports the PAMA Final Rule and Plans to Comment on the 2016 Preliminary Gapfill Determinations

Coalition’s message is to promote innovation in Advanced Diagnostic Laboratory Tests that improves patients’ outcomes Washington, D.C. – On June 17, the Centers for Medicare & Medicaid Services (CMS) released the final regulations to implement the new market based payment system for advanced diagnostic laboratory tests (ADLTs). The Coalition for 21st Century Medicine (C21) has … Continued

Welcome from the Coalition Steering Committee

Kim Popovits“The value of molecular diagnostics in delivering precision medicine in healthcare is simply way too high to ignore. Genomic medicine should and will be the future. In our efforts to help more patients improve their health outcomes, we must develop a framework for regulatory and reimbursement pathways that inspires innovation and investment in this important field.” – Kim Popovits, President and CEO, Genomic Health

Join the Coalition

US CapitolNever has your membership in the Coalition been more important than it is now, as we look forward to enacting the most significant health-related legislation of the decade and stand on the cusp of a revolution in the delivery of personalized health care. Join Now ยป

  • adaptive-biotechnologies_180x42_001a
  • aspira-labs-vermillion-company_180x42_001a
  • assurexhealth_180x42_001a
  • bioarray-therapeutics_180x42_001a
  • biocept_180x42_001a
  • Biodesix
  • biotheranostics_180x42_001a
  • cardiodx_180x42_001a
  • caredx_180x42_001a
  • Castle Biosciences Incorporated
  • counsyl_180x42_001a
  • creschendo_180x42_002a
  • foundation_180x42_001a
  • GE
  • genetic_180x42_001a
  • Genomic Health
  • guardant_180x42_001a
  • helomics_180x42_001a
  • KPCB_180x42_001a
  • mdxhealth_180x42_001a
  • myriad_180x42_002a
  • prometheus_180x42_001a
  • Sera Prognostics
  • veracyte_180x42_001a